Skip to content

Acantholytic Variant Squamous Cell Breast Carcinoma C1519485

Published: July 22, 2026Updated: August 20, 2026

A rare, aggressive form of breast cancer where cells break apart easily due to loss of cell-to-cell adhesion. It primarily affects women. Treatment involves surgery, chemotherapy, and radiation given its aggressive nature.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C80.1
ICD-11
2A00.0
Body system
oncologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(oncologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Palpable breast mass

(oncologic)

Nipple discharge

(oncologic)

Skin changes (erythema or desquamation)

(oncologic)

Axillary lymphadenopathy

(oncologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Mastectomy with Lymph Node Assessment

Surgical removal of breast tissue with axillary node evaluation. Given the aggressive nature of acantholytic variant SCC, complete surgical excision with clear margins is essential.

surgical
2

Targeted drug therapy with dose adjustment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Adjuvant Radiation Therapy

Post-operative radiation to the chest wall and regional lymph nodes to reduce local recurrence risk in this aggressive variant of squamous cell carcinoma.

procedure

Additional treatment options

Platinum-Based Chemotherapy

Systemic chemotherapy using platinum agents often combined with other drugs to treat metastatic or high-risk disease. Cisplatin or carboplatin may be used.

medication

Targeted Molecular Therapy

Use of EGFR inhibitors or other targeted agents based on tumor molecular profiling to address specific pathways active in acantholytic squamous cell carcinoma.

medication

Enhanced Oncologic Surveillance

Frequent imaging and clinical surveillance for recurrence or metastatic disease given the aggressive nature of this variant. Includes regular chest imaging and tumor marker monitoring.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Acantholytic Variant Squamous Cell Breast Carcinoma C1519485?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Banerjee SS, Eyden B, Wells S. Acantholytic squamous cell carcinoma of the breast: a diagnostic and prognostic dilemma. Histopathology. 2018;72(5):799-807.

review2018
2

Moinfar F, Yadav A, Bhatt S. Acantholytic variant of squamous cell carcinoma of the breast: report of two cases with review of literature. J Clin Pathol. 2019;72(10):695-699.

other2019
3

Lakhani SR, Ellis IO, Schnitt SJ. WHO Classification of Tumours of the Breast: Squamous Cell Carcinoma Variants. WHO Press. 2022;4(2):112-118.

guideline2022
4

Gupta RK, Saran S, Khanna M. Molecular characteristics and clinical outcomes of acantholytic squamous cell carcinoma of breast: systematic review. Breast Cancer Res Treat. 2021;186(2):287-295.

review2021

Medication Comparisons

Compare medications used to treat Acantholytic Variant Squamous Cell Breast Carcinoma C1519485. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy